Loading...
•
Dec 31, 2020
Schrodinger Q4 2020 Earnings Report
Schrödinger reported revenue growth driven by software uptake and strategic collaborations.
Key Takeaways
Schrödinger reported a 28% increase in total revenue for Q4 2020, driven by strong software revenue growth and contributions from a strategic collaboration with Bristol Myers Squibb. The company ended the year with a solid financial position, enabling continued investment in its computational platform and internal pipeline.
Total revenue increased by 28% in the fourth quarter of 2020.
Software revenue increased by 42% in the fourth quarter of 2020.
Entered into a strategic collaboration with Bristol Myers Squibb, receiving $55 million upfront.
Ended the fourth quarter with $643.2 million in cash, cash equivalents, restricted cash and marketable securities.
Schrodinger
Schrodinger
Schrodinger Revenue by Segment
Revenue by Segment
Software Products and Services Revenue
CapyFin.comDrug Discovery Revenue
CapyFin.com Forward Guidance
Schrödinger expects total revenue to range from $124 million to $142 million, with software revenue expected to range from $102 million to $110 million, and drug discovery revenue expected to range from $22 million to $32 million for the fiscal year ended December 31, 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income